Cresco Labs closes PharmaCann acquisition for US$50 million
Cresco Labs announced the closing of its acquisition of 100% of PharmaCann Penn, LLC for aggregate consideration of US$50 million.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.